エピソード

  • 201 - Google's Humanoid AI, Medicare Drug Subsidy Ends, Microsoft and Amazon Cloud Surge

    201 - Google's Humanoid AI, Medicare Drug Subsidy Ends, Microsoft and Amazon Cloud Surge
    2026/08/01
    Vic and Marcus discuss the return of Trump's tariffs, the Federal Reserve's evolving approach under Chairman Warsh, and the continued strength of AI infrastructure as Microsoft and Amazon report surging cloud growth. They cover major healthcare funding rounds, including AI revenue cycle management, vision therapies, and an AI-powered smart toilet for early disease detection. The episode also examines FTC action against Hims & Hers, the end of Medicare drug plan subsidies, Medicaid work requirement rulings, payer earnings, ACA market instability, rising uninsured rates, hospital consolidation, biotech acquisitions, the Ebola outbreak in the Democratic Republic of Congo, new wearable health monitoring technology, blockchain adoption across finance, AI agents handling payments, AI safety legislation, and Google's latest humanoid robotics advances.cognitive decline remind us that prevention and early detection remain the frontier of clinical care.Story Lineup1 — In This Economy00:33 -Story 1: Healthcare Faces 100% Drug Tariff Shock Starting July 31 [Becker's Hospital Review]8:54 - Story 2: Fed Holds Rates Steady but Internal Split Signals Future Pressure on Inflation [WSJ]13:13 - Story 3: Microsoft Azure Exceeds $100B as Tech Giants Diverge on AI Spending ROI [WSJ]2 — VC Deal Review14:29 - Story 1: Candid Health Raises $120M Series D for AI-Powered Revenue Cycle Management [MedCity News]16:49 - Story 2: Claris Biotech Emerges with $118M Series B for Corneal Disease Therapy [Fierce Biotech]18:03 - Story 3:Throne Science Raises $10M Series A for AI Toilet Sensor in Colorectal Cancer Screening [MedCity News]3 — Policy20:22 - Story 1: FTC Sues Hims & Hers Over Illegal Data Sharing With Meta and Snapchat [Gizmodo]22:59 - Story 2: CMS Ends Medicare Drug Plan Premium Subsidies; Seniors Face Higher 2027 Costs [WSJ.com: Health]26:57 - Story 3: Federal Court Upholds Medicaid Work Rules; Policy Shift Takes Effect [Becker's Hospital Review]4 — Health Payors28:07 - Story 1: Cigna Raises 2026 Outlook on Strong Q2 Employer Plan Growth; $1.7B Profit [Becker's Hospital Review]28:54 - - Story 2: "Back On Track" Centene Swing more than $1B in Profit in Q230:50 - Story 3: Humana Maintains Adjusted Earnings Outlook, Underwhelming Investors 31:44 - Story 4: Humana Retreats From Lower-Margin Medicare Advantage Plans Ahead of 2027 [Healthcare Dive - Latest News]32:50 - Story 5: ICHRA Adoption Slowed by ACA Exchange Instability and Affordability Concerns [Healthcare Dive]5 — Health Systems34:09 - Story 1: Hospital Uninsured Patient Volume Surges After ACA Subsidy Cliff [NYT]36:27 - Story 2: 29 Large Health Systems Announce M&A: Consolidation Boom Driven by Scale and Capital Access [Becker's Hospital Review]6 — Pharma & Novel Therapies38:39 - Story 1: J&J Partners With Sail Biomedicines on In Vivo CAR-T Therapy; $785M Upfront, $2.85B Acquisition Option [MedCity News]39:57 - Story 2: Argenx Acquires Forte Biosciences for $2B; CD122 Antibody Targets Autoimmune Orphans [MedCity News]7 — About Health & Us / The Clinician's Voice41:12 - Story 1: DRC Ebola Outbreak Now Second-Deadliest Ever; 1,500+ Deaths in Record-Breaking Two Months [The New York Times]42:44 - Story 2: Smart Ring Sensors Track Nutrition and Insulin Response via Finger Sweat; New Biomarker Frontier [Gizmodo]8 — Web344:21 - Story 1: BNY Mellon Targets $8.6 Trillion Transfer Agency Market via Blockchain; Major Traditional Finance Adoption [CoinDesk]45:33 - Story 2: Institutional Crypto Trading Hits Record 72% as Wall Street Dampens Market Volatility [CoinDesk]47:59 - Story 3: MoonPay Embe...
    続きを読む 一部表示
    1 時間
  • 200 - AI, Healthcare, and the Future We've Been Tracking

    200 - AI, Healthcare, and the Future We've Been Tracking
    2026/07/25

    Vic and Marcus celebrate the 200th episode of the Health Further podcast while reflecting on four years of healthcare transformation, innovation, and policy change. They discuss the financial pressures facing hospitals from Medicaid funding cuts, the future of AI in healthcare, automation's impact on jobs, Google's massive AI investments, OpenAI's cybersecurity incident, the growing debate over open versus closed AI models, and why healthcare leaders may be underestimating the pace of disruption across the industry.

    Story Lineup


    8:35 - Story 1: LA Safety-Net Hospital Braces for $80–100M Annual Medicaid Hit From HR 1 Cuts [Becker's Hospital Review]


    10:30 - Story 2: Trump Administration Pauses $1B in Medicaid Payments [HealthCare Dive]


    13:33 - Story 3: OpenAI Launches ChatGPT Health Nationwide; Claims Models Reason at Clinician Level, Intensifying Healthcare AI Adoption Debate [The Verge]


    18:01 - Story 4: Molina Plans Further ACA Exchange Exits in 2027 Despite Stable Medicaid and Strong MA Growth [Healthcare Dive]

    30:14 - Story 5: Travis Kalanick's Atoms Robotics Raises $1.7B Series C Led by a16z [TechCrunch]



    45:27 - Story 6: Big Tech's AI Capex Binge Raises Doubts on Returns as Google, OpenAI Pour Billions Into Infrastructure [The New York Times]


    57:30 - Story 7: OpenAI's GPT Models Escaped Sandbox and Autonomously Hacked Hugging Face in Test Gone Wrong—Major AI Safety Incident [WSJ]
    続きを読む 一部表示
    1 時間 4 分
  • 199 - Fintech Consolidation, AI Commoditization, and the Hospital Profitability Crisis

    199 - Fintech Consolidation, AI Commoditization, and the Hospital Profitability Crisis
    2026/07/19
    Vic and Marcus discuss easing inflation, the growing number of workers locked out of the job market, and major venture funding rounds for AI-powered healthcare companies. They examine proposed Medicare physician payment cuts, prior authorization policy, Medicaid challenges, insurer earnings, and mounting financial pressure on hospitals as care continues shifting to outpatient settings. They also cover Eli Lilly's latest acquisition, a first-of-its-kind cholesterol pill, food safety concerns, new wearable health technology, Visa's stablecoin platform, AI agent commerce, and China's rapid advances in artificial intelligence that are reshaping global competition.Story Lineup1 — In This Economy📊 Economy Vitals — this week's macro readings6:56 - Story 1: 📉 Inflation — CPI (June, rel. Jul 14): CNBC8:09 - Story 2:👷 Labor — initial jobless claims (wk ending Jul 4): https://www.wsj.com/economy/jobs/unemployment-long-term-job-market-629199f9?mod=Searchresults&pos=1&page=12 — VC Deal Review10:05 - Story 1: Chai Discovery Raises $400 Million Series C for AI Molecule Design Platform Adopted by Pharma Giants [Fierce Biotech]11:07 - Story 2: Neko Health Secures $700 Million Series C for U.S. Clinical Diagnostics Expansion [MedCity News]3 — Policy12:16 - Story 1: CMS Proposes 2027 Physician Pay Cuts Amid Broader Medicare Value-Based Payment Reforms [Healthcare Dive]13:46 - Story 2: Senate Republicans Block Democratic Bid to Repeal Medicare AI Prior Authorization Pilot [Healthcare Dive]4 — Health Payors17:30 - Story 1: UnitedHealth Reports $5.5 Billion Q2 Profit, Raises 2026 Guidance on Cost-Control Discipline [Healthcare Dive]18:17 - Story 2: Elevance Shuts Down D.C. Medicaid Business, Eyes Additional Market Exits [Healthcare Dive]19:35 - Story 3: CVS/Caremark Settles FTC Insulin Pricing Case, Required to Stop Formulary Bias Toward Higher-Cost Drugs [Healthcare Dive]5 — Health Systems21:09 - Story 1: HCA Healthcare Slashes 2026 Earnings Forecast After Losing $400 Million in ACA Plan Dropouts [Healthcare Dive]24:21 - Story 2: Health Systems Race to Build Ambulatory Surgery Center Networks as Outpatient Revenue Growth Outpaces Inpatient [Becker's Hospital Review]6 — Pharma & Novel Therapies28:48 - Story 1: Eli Lilly Acquires AtaiBeckley for $2.8 Billion, Entering Psychedelic-Based Mental Health Market [MedCity News]30:23 - Story 2: Merck's Lipfendra Approved as First-of-Kind Oral Cholesterol Drug Beyond Statin Monotherapy [WSJ.com: Health]7 — About Health & Us / The Clinician's Voice32:56 - Story 1: Cyclospora Outbreak Spreads to 30+ States; CDC Struggles to Identify Source Amid Surveillance Capacity Gaps [WSJ]38:55 - Story 2: New Smart Ring Technology Enables Non-Invasive Blood Pressure Measurement Without Calibration [9to5Mac]8 — Web341:48 - Story 1: Visa Launches Institutional Stablecoin Platform for Banks and Fintechs; Enables Digital Dollar Integration [Decrypt Media]9 — The AI Tracker52:32 - Story 1: China's Moonshot AI Releases Kimi K3 Model, Claiming Parity with GPT-5.6 and Anthropic Systems at Lower Cost [Axios]1:00:40 - Story 2: Meta Negotiates ~$10 Billion Compute Lease to Anthropic; AI Infrastructure Bottleneck Fuels New Business Models [The New York Times]1:07:57 - Story 3: Former Mayo Clinic Leader Sues System Over Alleged AI Safety and Privacy Concerns Retaliation [MedCity News]1:15:36 - Story 4: https://x.com/chamath/status/2077018028852588687?s=20
    続きを読む 一部表示
    1 時間 24 分
  • 198 - Healthcare's Consolidation Crunch Meets AI's Mega Buildout—And New Regulatory Crossroads

    198 - Healthcare's Consolidation Crunch Meets AI's Mega Buildout—And New Regulatory Crossroads
    2026/07/11
    Vic and Marcus discuss uncertainty around Federal Reserve interest rate policy, continued strength in AI infrastructure and semiconductor markets, and major venture funding across biotech and value-based care. They examine proposed NIH research policy changes, the impact of Medicaid enrollment reductions and rising ACA premiums, Medicare Advantage legal disputes, healthcare bankruptcies, labor strikes, and Ascension's acquisition of Williamson Health. They also cover major pharmaceutical acquisitions, expanding access to peptides, advances in brain-computer interfaces, the challenges of integrating wearable data into clinical care, blockchain's growing role in banking, China's evolving AI strategy, Apple's lawsuit against OpenAI, and the rapid expansion of AI data center infrastructure.Story Lineup1 — In This Economy00:58 - Story 1: Fed Chair Warsh Signals Divided Views on Inflation Path Amid AI Buildout 2:12 - Story 2: SK Hynix Lands $26B Nasdaq IPO, World's Largest Non-US Chip Offering [CNBC]2 — VC Deal Review4:00 - Story 1: Leo Cancer Care Secures $65M Series D for Upright Radiotherapy System Ahead of IPO [Fierce Biotech]4:42 - Story 2: MeiraGTx Secures $400M Growth Capital for Gene Therapy Commercialization [Fierce Biotech]5:57 - Story 3: Pearl Health Raises $110M to Scale Value-Based Care Infrastructure for Medicare [MedCity News]3 — Policy7:04 - Story 1: Trump OMB Grant Overhaul Draws 99K Comments From Scientists Warning of NIH Politicization [The New York Times]9:06 - Story 2: Biotech Revenue Projections Darkened by Trump Tax Bill's Medicaid Enrollment Impact [Fierce Biotech]4 — Health Payors11:39 - Story 1: ACA Marketplace Insurers Propose 14% Median Premium Hike for 2027—Second Straight Double-Digit Increase [Healthcare Dive]13:54 - Story 2: Elevance Healthcare Sues CMS Over Medicare Advantage Stars Recalculation, Alleging $115M Loss [Healthcare Dive]15:39 - Story 3: Alignment Healthcare Faces Whistleblower Accounting Fraud Lawsuit Over Capex Misclassification [Healthcare Dive]5 — Health Systems16:56 - Story 1: Healthcare Bankruptcies Accelerate in 2026, Driven by Staffing Costs and Reimbursement Pressure [Becker's Hospital Review]17:49 - Story 2: Massachusetts' Largest Healthcare Strike Ever: 4,000+ MGB Nurses and Home Health Staff Walk Out Over Wages [MedCity News]20:33 - Story 3: Ascension Acquires Williamson Health for $1B, Securing Regional Hospital Consolidation in Tennessee [Healthcare Dive]6 — Pharma & Novel Therapies22:01 - Story 1: Vertex Acquires Crinetics for $10B—Largest Deal in Company History—Targeting Endocrine Diseases [Fierce Biotech]24:30 - Story 2: FDA Advisory Committee to Vote on Peptide Regulation July 23–24—Major Inflection for GLP-1s [Becker's Hospital Review]26:57 - Story 3: AstraZeneca's Late-Stage Cardiac Trial Failure Narrows Pipeline Beyond Oncology [WSJ]7 — About Health & Us / The Clinician's Voice28:21 - Story 1: Non-Surgical Brain-Computer Interfaces Increasingly Match Surgical Performance, Reshaping BCI Strategy [MedCity News]30:18 - Story 2: Physicians Cite Reimbursement and Workflow Barriers to Actionable Wearable Data Adoption [Healthcare Dive]8 — Web336:88 - Story 1: Circle Wins Final OCC Approval to Open National Trust Bank—First Crypto Firm to Secure Charter [The Block]37:28 - Story 2: SWIFT Launches Blockchain Ledger Enabling 24/7 Tokenized Payments for 17 Major Global Banks [The Block]39:09 - Story 3: CFTC Chair Warns Regulators Will 'Write All the Rules' for Crypto If Clarity Act Stalls [The Block]9 — The AI Tracker43:15 - Story 1: Beijing Weighs Limits on Homegrown AI Models—Escalating US-China AI Geopolitics [WSJ]46:10 - Story 2: - https://www.wsj.com/tech/apple-openai-lawsuit-f86bd58c?mod=breakingnews 46:52 - Story 3:
    続きを読む 一部表示
    55 分
  • 197 - Frontier AI as Foreign Policy, Medicare Expands Weight-Loss Drugs, and Health Systems Face the Outpatient Reckoning

    197 - Frontier AI as Foreign Policy, Medicare Expands Weight-Loss Drugs, and Health Systems Face the Outpatient Reckoning
    2026/07/04
    Vic and Marcus discuss slowing U.S. job growth, Meta's move into AI cloud infrastructure, record venture funding driven by AI, and what those trends mean for the technology sector. They examine Medicare coverage for weight loss drugs, proposed CMS changes affecting hospitals, Medicaid work requirement lawsuits, and the continued shift of care away from hospitals. They also cover major healthcare advances, including expanded gene therapy for children with sickle cell disease, AI-powered drug discovery partnerships, and the first FDA-approved Treg cell therapy. The episode concludes with the record-low U.S. death rate, stablecoin adoption, blockchain tokenization, and the growing AI competition between the U.S. and China.Story Lineup1 — In This Economy3:47 - Story 1: U.S. labor market cools sharply: June jobs report shows only 57,000 positions added [WSJ]7:14 - Story 2: Meta Is Planning a Cloud Business to Sell AI Computing Power [Bloomberg]2 — VC Deal Review10:30 - Story 1: Global startup investment surges to record $510B in H1 2026 as AI exits accelerate [Crunchbase News]12:40 - Story 2: Beeline raises $126M Series A extension on heels of $300M launch, bolsters autoimmune pipeline [Fierce Biotech]3 — Policy14:15 - Story 1: Medicare begins covering GLP-1 weight-loss drugs for seniors at $50/month out-of-pocket starting July 1 [WSJ]15:17 - Story 2: CMS targets 340B drug discount program and site-neutral pay in 2027 outpatient rule overhaul [Becker's Hospital Review]21:20 - Story 3: Twenty-six states sue Trump administration over Medicaid work requirements rule implementation [Healthcare Dive]4 — Health Payors28:59 - Story 1: Evernorth commits $100M through 2028 to AI-powered specialty pharmacy program expansion [MedCity News]5 — Health Systems30:28 - Story 1: 10-year outlook: outpatient volumes set to grow 20% while inpatient discharges rise just 7%, reshaping hospital economics [Becker's Hospital Review]32:45 - Story 2: Large health system EHR migrations collapse 40% year-over-year as Epic dominance and vendor delays lock in incumbency [Becker's Hospital Review]6 — Pharma & Novel Therapies37:55 - Story 1: FDA expands Vertex's Casgevy CRISPR gene therapy to children as young as 2 with sickle cell disease [Becker's Hospital Review]39:36 - Story 2: Takeda partners with Insilico on AI drug discovery platform worth up to $600M across multiple therapeutic areas [WSJ]41:21 - Story 3: Orca Bio's Tregzi becomes first FDA-approved regulatory T cell therapy for graft-versus-host disease [MedCity News]7 — About Health & Us / The Clinician's Voice43:45 - Story 1: U.S. Death Rate Falls to Its Lowest Point on Record [WSJ]8 — Web346:52 - Story 1: Open USD stablecoin launch backed by Visa, Mastercard, and Google challenges USDC/USDT incumbents [Decrypt Media]49:41 - Story 2: Ondo launches SEC-compliant tokenized ETF and equities with Ethereum settlement, signaling institutional crypto infrastructure maturation [The Block]9 — The AI Tracker51:28 - Story 1: Health systems pivot from proving AI efficacy to scaling implementations; inflection point for health tech adoption [Becker's Hospital Review]56:53 - Story 2: Anthropic unveils Claude Science AI workbench for pharma research execution ahead of anticipated IPO [MedCity News]59:52 -Story 3: New Chinese AI model matches Anthropic Claude performance; likely to reshape White House AI policy overhaul [WSJ]1:08:23 - Story 4: OpenAI proposes handing Trump administration 5% stake [FT]
    続きを読む 一部表示
    1 時間 16 分
  • 196 - PCE at 4.1%, GLP-1s for Kids, and OpenAI's Custom Chip — Health:Further Weekly

    196 - PCE at 4.1%, GLP-1s for Kids, and OpenAI's Custom Chip — Health:Further Weekly
    2026/06/27
    Vic and Marcus discuss rising inflation, the AI-driven data center boom, and growing concerns about the long-term economic impact of artificial intelligence. They examine major healthcare venture funding rounds, the resurgence of biotech investment, Medicare policy changes, PBM scrutiny, rising healthcare spending driven by GLP-1 drugs, rural hospital transformation, chemotherapy drug shortages, new cancer treatments, and the growing use of Wegovy in children. The episode also covers Bitcoin's sharp decline, venture capital consolidation, and the future of healthcare innovation.Story Lineup1 — In This Economy1:59 - Story 1: PCE Hits 4.1% — The Iran War, the AI Build-Out, and a Fed Caught in the Middle [WSJ]7:13 - Story 2: AI Infrastructure Is Inflation's New Structural Driver [WSJ]16:17 - Story 3: AI Bubble Fears Trigger Nasdaq Rout; KOSPI Crashes 10% Overnight [Axios]18:02 - Story 4: Scott Bessent: Hamilton Inspires Trump Economic Statecraft [WSJ]2 — VC Deal Review20:33 - Story 1: Menlo Ventures Closes $3B Fund — Biggest Ever — on the Back of Its Anthropic Bet [TechCrunch]28:49 - https://www.fiercehealthcare.com/ai-and-machine-learning/assort-health-scores-120m-series-c-scale-voice-ai-agent-platform-healthcare 30:21 - Story 2: Cadence Closes $100M Series C at $1.23B Valuation for AI-Powered Chronic Care [MedCity News]31:33 - Story 3: Ollin Biosciences Hauls In $330M Series B to Challenge Roche's Vabysmo in Wet AMD [Fierce Biotech]3 — Policy32:34 - Story 1: U.S. Health Spending Hits $5.7 Trillion in 2025 — GLP-1 Costs Are a Primary Culprit [Healthcare Dive]34:43 - Story 2: 31 House Democrats Demand Transparency on CMS's AI Prior-Auth Pilot in Medicare [Healthcare Dive]4 — Health Payors38:35 - Story 1: Florida Opens Antitrust Probe Into CVS/Caremark as State-Level PBM Crackdown Accelerates [Healthcare Dive]43:07 - Story 2: Abarca Health and LucyRx Merge to Build a Scaled Independent PBM Alternative [MedCity News]44:33 - Story 3: Medicare Advantage at an Inflection: Reset or Retreat? [MedCity News]5 — Health Systems50:11 - Story 1: Cancer Chemo Shortages Force Hospitals to Consider Rationing [Becker's]52:33 - Story 2: Eli Lilly Halts 340B Discounts for Non-Compliant Hospitals, Triggering Legal Battle [MedCity News]55:39 - Story 3: States Are Using the $50B Rural Health Fund to Shrink Hospitals, Not Transform Care [Healthcare Dive]6 — Pharma & Novel Therapies57:38 - Story 1: FDA Approves Two New Drugs to Replace Chemo as First-Line Treatment for Triple-Negative Breast Cancer [WSJ]59:23 - Story 2: Pfizer's First Major ADC From the $43B Seagen Acquisition Fails Phase 3 [Fierce Biotech]59:47 - Story 3: AbbVie Pays $10.9B for Apogee to Challenge Dupixent in Eczema [Fierce Biotech]7 — About Health & Us / The Clinician's Voice1:00:39 - Story 1: Wegovy for Elementary Schoolers: Pediatricians Turn to GLP-1s as Childhood Obesity Rates Climb [WSJ]8 — Web31:03:47 - Story 1: Bitcoin Hits Multi-Year Low of $58K as BTC and ETH Each Post 20%+ Monthly Losses [CoinDesk]9 — The AI Tracker1:06:18 - Story 1: Anthropic Accuses Alibaba of Running a 'Brazen' Campaign to Illicitly Access Claude [WSJ]1:10:30 - Story 2 : https://www.lennysnewsletter.com/p/glm-52-why-im-replacing-opus-in-claude1:12:32 - Story 3: OpenAI Unveils 'Jalapeño' — Its First Custom AI Inference Chip Built With Broadcom [WSJ]1:13:05 - Story 4: X - Satya Nadella - "Frontier without an ecosystem is not stable." [X]
    続きを読む 一部表示
    1 時間 21 分
  • 195 - Warsh's Fed, the Hormuz Deal, Anthropic's Export Ban, and the Retatrutide Black Market! Ft. Ash Shehata

    195 - Warsh's Fed, the Hormuz Deal, Anthropic's Export Ban, and the Retatrutide Black Market! Ft. Ash Shehata
    2026/06/20
    Marcus welcomes Ash Shehata, former KPMG executive and current Impact Advisors leader, as guest host for a wide-ranging discussion on healthcare, technology, finance, and policy. They examine the Federal Reserve’s evolving approach under Kevin Warsh, the economic implications of reopening the Strait of Hormuz, and SpaceX’s historic IPO alongside its reported Cursor acquisition. The conversation also covers the resurgence of biotech and pharmaceutical M&A, FDA flexibility around gene therapies, rural hospital transformation funding, information blocking enforcement, Medicare Advantage contract disputes, PBM transparency battles, smart hospital rooms, longevity medicine, GLP-1 coverage expansion for seniors, digital assets, tokenized stocks, and the growing role of AI across healthcare and society.Story Lineup1 — In This Economy2:34 - Story 1: Warsh's Fed Ditches Forward Guidance — Markets Brace for Hikes [NYT]New Fed Chair Kevin Warsh holds rates but abandons forward guidance at his first FOMC presser, sending rate-hike odds higher and rattling markets — a fundamental shift in central bank posture.Tension / discussion: Is Warsh's opacity a feature or a bug? Does removing guidance restore Fed credibility or introduce dangerous ambiguity for markets and borrowers?also: Axiosalso: WSJ6:22 - Story 2: U.S.-Iran Deal Reopens Hormuz, Sends Oil Prices Tumbling [NYT]Strait of Hormuz reopens under a U.S.-Iran MOU signed ahead of schedule, driving oil prices lower, gas below $4 nationally, and stocks higher — the biggest macro relief valve in months.Tension / discussion: How durable is this deal? A fragile MOU with Iran may give markets false comfort while the underlying geopolitical fault lines remain very much alive.also: Axiosalso: Axios11: 07 - Story 3: SpaceX Acquires AI Coding Agent Cursor for $60 Billion [WSJ]SpaceX deploys post-IPO capital in a $60B all-stock acquisition of Cursor, extending Musk's empire into enterprise AI tooling and setting a new benchmark for AI startup valuations.Tension / discussion: Does a $60B price tag for a coding agent represent genuine enterprise value or peak AI deal froth? And what does it mean that a rocket company is now a software conglomerate?also: Strictly VC2 — VC Deal Review14:52 - Story 1: Biopharma M&A Is Back: PwC Reports Strongest Deal Quarter Since 2020 [Fierce Biotech]PwC data shows life sciences deal values exceeded $65B in Q1 2026, the strongest quarter in six years — a macro signal that the biopharma financing cycle has turned.Tension / discussion: Is this a genuine ecosystem recovery or a buyer's market where big pharma is snapping up distressed assets at favorable prices while smaller biotechs remain starved for capital?17:58 - Story 2: Kardigan Prices $400M Upsized IPO to Fund Cardiovascular Drug Push [Endpoints]Cardiovascular biotech Kardigan prices above expectations in a upsized $400M IPO, the latest evidence that the biotech IPO window is open for the right therapeutic areas.Tension / discussion: Cardiovascular drugs have a historically brutal Phase 3 attrition rate — does the IPO enthusiasm reflect genuine science confidence or investor FOMO in a hot market?FYIInStride Raises $30M Series C for Pediatric Mental Health [MedCity News]Altaris Acquires AI Drug Dev Platform Simulations Plus for $375M [Fierce Biotech]Vedana Therapeutics Emerges With $46M for Next-Gen Migraine Prevention [Fierce Biotech]3 — Policy20:01 - Story 1: FDA Reverses Course on uniQure Huntington's Gene Therapy — A Signal of New Regulatory Flexibility [MedCity News]FDA greenlights uniQure's Huntington's gene therapy for accelerated approval filing after reversing a prior requirement for an additional trial — a bellwether for how the agency will treat the broader rare disease pipeline.Tension / discussion: Is this welcome regulatory modernization for patients with no other options, or does loosening approval standards for gene therapies create a safety accountability gap that will haunt the field?also: STAT Newsalso: Fierce Biotech23:35 - Story 2: Rural Hospitals Told to 'Hang On' as Medicare Opt-Outs Accelerate and Closure Funds Lag [Becker's]Rural hospital leaders are skeptical the $50B HR 1 transformation fund arrives before closures hit, while a parallel JAMA analysis shows rural physicians are opting out of Medicare faster than anyone is tracking.Tension / discussion: Is the Rural Health Transformation Program a genuine lifeline or a political promise that arrives too late for the hospitals and patients that need it most?also: Becker's31:28 - Story 3: Trump HHS Launches Active Information-Blocking Enforcement Under 21st Century Cures Act [Becker's Hospital Review]After years of soft implementation, HHS is now actively enforcing information-blocking rules — a compliance wake-up call for health systems, EHR vendors, and health IT companies.Tension / discussion: Will enforcement pressure actually unlock data interope...
    続きを読む 一部表示
    1 時間 21 分
  • 194 - Inflation Rises, SpaceX Demand Surges, and Apple’s AI Strategy Takes Shape

    194 - Inflation Rises, SpaceX Demand Surges, and Apple’s AI Strategy Takes Shape
    2026/06/13
    Vic and Marcus discuss rising inflation tied to escalating conflict in Iran and the broader economic implications for energy markets, review major venture capital and healthcare startup funding activity including surgical AI company Uncovr, examine developments in AI adoption and productivity across healthcare, analyze the competitive landscape between Apple and leading AI labs, explore IPO activity ranging from SpaceX demand to healthcare and pharmaceutical offerings, and close with a discussion on robotics, automation, and the impact of humanoid robots on future labor markets.LinksStory 1: Economy5:16 - Inflation Jumps as Iran War Intensifies Price Squeeze NYT9:16 - SpaceX IPO Draws at Least $5 Billion Order From BlackRockStory 2: VC rundown15:32 - Surgical AI Startup Uncovr Emerges from Stealth with $7M Seed Funding HIT16:55 - Stepful raises $55M for healthcare training platform Mobi HealthStory 3: Price transparency17:40 - Kennedy & Oz Discuss Price transparency on XStory 4: CMS Top 5 Priorities22:39 - The 5 Areas Where Dr. Oz Says CMS Can Make Healthcare More Affordable MedCityStory 5: Drug prices inside EMRs26:41 - BCBS of Massachusetts partners for lower-cost drug alternatives Healthcare FinanceStory 6: GSK Oncology28:21 - GSK to Buy Nuvalent for $10.6 Billion in Oncology Push WSJStory 7: GLP-1 Pills28:40 - Novo Nordisk Weight-Loss Pill Prescriptions Hit Three Million Since Launch WSJStory 8: Pharma IPO in Canada30:01 - Apotex Shares Rally as Trading Begins Following Pricing of C$1.3 Billion IPO WSJStory 9: Wearable Showdown 31:33 - The Wearable Showdown: Oura Ring 5 vs. Fitbit Air vs. Whoop MG vs. Apple Watch WSJStory 10: Agent Payments34:41 - Coinbase Launches Tool That Lets AI Agents Trade Crypto and Make Payments for Users Decrypt35:35 - Mastercard Launches Agent Pay for Machines, Ripple and XRPL Join 30+ Partners to Power AI-Driven Commerce MerkleStory 11: Abridge growth38:53 - Abridge picks up strategic investment from Eli Lilly, expands payer, research workflows Fierce HealthcareStory 12: Claude Fable540:08 - Anthropic Releases New ‘Mythos-Class’ Model to General Public With Guardrails WSJ41:16 - bWe've Never Seen an AI Like This (Claude Fable 5) YouTubeStory 13: Price War Coming?1:05:55 - OpenAI Considers Drastic Price Cuts, Anticipating War for Users With Anthropic WSJStory 14: Apple Developer Conf1:07:37 - Apple Unveiled the New Siri AI. Here Are the Key Takeaways. WSJStory 15: Apple Developer Conf1:12:47 - Driverless Trucks Are Here—and They’re Delivering Bags of Doritos WSJ
    続きを読む 一部表示
    1 時間 20 分